HomeAI · summaries
Storia in 3 fonti
Amgen’s lung cancer treatment Imdelltra notches major new victory
Amgen's Imdelltra plus AstraZeneca's Imfinzi improves overall survival in extensive-stage small cell lung cancer in Phase 3.
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
fiercepharma.com
Amgen’s DLL3-targeted Imdelltra scores overall survival win in first-line small cell lung cancer
In further validation of the DLL3 target pioneered by Amgen’s Imdelltra, the T-cell engager has delivered an overall survival win in first-line small cell lung cancer (SCLC). |…
- ·
endpoints.news
Amgen’s lung cancer treatment Imdelltra notches major new victory
Amgen's Imdelltra plus AstraZeneca's Imfinzi improves overall survival in extensive-stage small cell lung cancer in Phase 3.
